| Title: | Real-world evidence for the effectiveness of vitamin D supplementation in reduction of total and cause-specific mortality |
| Journal: | Journal of Internal Medicine |
| Published: | 17 Oct 2022 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/36208176/ |
| DOI: | https://doi.org/10.1111/joim.13578 |
| Citations: | 15 (14 in last 2 years) as of 8 Aug 2024 |
Publication 10583
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BACKGROUND: Meta-analyses of randomized controlled trials (RCTs) have demonstrated the efficacy of vitamin D supplementation for reduced cancer mortality, all-cause mortality, and respiratory tract infections. However, whether and to what extent this translates into effectiveness in real-world practice is unknown.</p>
METHODS: We assessed the association of vitamin D supplement use (as an over-the-counter drug or as part of a multivitamin product), vitamin D deficiency (25-hydroxyvitamin D, 25[OH]D <30 nmol/L), and insufficiency (25[OH]D 30 to <50 nmol/L) with all-cause and cause-specific mortality in 445,601 participants, aged 40-73 years, from the UK Biobank cohort.</p>
RESULTS: A total of 4.3% and a further 20.4% of the study participants reported regularly taking vitamin D or multivitamin supplements, respectively. Still, the majority had either vitamin D deficiency (21.0%) or insufficiency (34.3%). We detected 49 independent determinants of vitamin D deficiency and vitamin D supplement use and used them to adjust Cox regression models for all mortality outcomes. A total of 29,107 (6.5%) participants died during a median follow-up time of 11.8 years. Both vitamin D deficiency and insufficiency were strongly associated with all mortality outcomes. Self-reported vitamin D supplement use (83% over-the-counter/17% prescription drugs) and multivitamin intake were significantly associated with 10% and 5% lower all-cause mortality, respectively. Furthermore, regular vitamin D supplement users had 11%, 11%, and 29% lower cancer, cardiovascular disease, and respiratory disease mortality than nonusers, respectively (not significant for cardiovascular disease mortality).</p>
CONCLUSION: This large study suggests that in the real world, the efficacy of vitamin D supplements in reducing mortality may be at least as good as observed in RCTs.</p>
7 Authors
- Sha Sha
- Thi Mai Ngoc Nguyen
- Sabine Kuznia
- Tobias Niedermaier
- Anna Zhu
- Hermann Brenner
- Ben Schöttker
1 Application
| Application ID | Title |
|---|---|
| 62848 | Vitamin D and health outcomes |
Enabling scientific discoveries that improve human health